Xu, who recently published a blog post entitled "How close are we to a COVID-19 cure? A biotech VC perspective" says he anticipates a potential vaccine to be developed by winter, early spring of 2021, while a treatment, he says, will take a considerably longer time frame.
Arix Bioscience associate talks through current promising coronavirus treatments and vaccines
Quick facts: Arix Bioscience PLC
Price: 85.66 GBX
Market Cap: £116.16 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Arix Bioscience PLC named herein, including the promotion by the Company of Arix Bioscience PLC in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE